Zotarolimus stent matches everolimus DES in TWENTE
San Francisco, CA - Another randomized controlled "real-world" trial has demonstrated noninferiority of the Resolute zotarolimus-eluting stent (Medtronic) against the market-leading Xience everolimus-eluting stent (Abbott) at one year. ...
TCT: Resolute, Xience V produce similar results in face-offCardiovascular Business
Medtronic Resolute Drug-Eluting Stent Equals Abbott Xience V in Second Major StudyAngioplasty.Org

all 3 news articles »